Plain-English translation of NCT07085507 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it is safe and works well for people with multiple sclerosis. The study starts by giving the medication to healthy volunteers in carefully increasing doses to understand how the body processes it and what side effects it might cause. Once the research team learns the safest doses, they will test the medication in people who have been diagnosed with MS.
Multiple sclerosis is a serious condition where the immune system attacks the nervous system, causing progressive disability. Researchers are developing new treatments like this medication to help slow or stop this damage and improve outcomes for people living with MS.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll participate in one of three parts depending on your health status. Healthy volunteers may receive a single dose of the medication (or placebo) and have their blood and spinal fluid tested, or receive multiple doses over time, or take the medication in different eating conditions to see how food affects how the body processes it. If you have MS, you'll attend weekly visits where you'll receive the medication and have regular check-ups and lab tests to monitor your safety and how well the treatment works.
AI-generated summary from trial data · Aug 1, 2026 · Not medical advice
Australia